Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children

Identifieur interne : 000179 ( France/Analysis ); précédent : 000178; suivant : 000180

Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children

Auteurs : Chantal Loirat [France] ; Jean-Pierre Girma [France] ; Céline Desconclois [France] ; Paul Coppo [France] ; Agnès Veyradier [France]

Source :

RBID : ISTEX:5644B9A6905FD47BEF714BCEA5AB40E6FB4281A5

English descriptors

Abstract

Abstract: Thrombotic thrombocytopenic purpura (TTP) related to a severely deficient activity of the von Willebrand factor cleaving protease, ADAMTS (A Disintegrin And Metalloprotease with ThromboSpondin type 1 repeats) 13, is a life-threatening event, the onset of which may occur as early as childhood. TTP is either inherited (Upshaw-Schulman syndrome) via ADAMTS13 gene mutations (neonatal onset) or acquired via anti-ADAMTS13 autoantibodies (childhood onset). TTP is due to platelet- and von-Willebrand-factor-rich thrombi of the microvasculature, inducing mechanical hemolytic anemia, consumption thrombocytopenia, and multivisceral ischemia. Clinical course consists of relapsing acute events triggered mostly by infections, associated icterus and hyperbilirubinemia, severe hemolytic anemia with schistocytosis and a negative Coombs test, severe thrombocytopenia, and sometimes symptoms related to visceral ischemia (renal failure, central nervous system vascular events, other organ failure). The recently available ADAMTS13 laboratory investigation combining measurement of ADAMTS13 activity in plasma, search for an ADAMTS13 circulating inhibitor, and anti-ADAMTS13 IgG and ADAMTS13 gene sequencing is a crucial addition to TTP diagnosis. Plasma exchanges are first-line treatment of acquired TTP, combined with steroids and immunosuppressive drugs. Curative treatment of acute events in Upshaw-Schulman syndrome relies on plasma infusions (provider of active ADAMTS13). Guidelines for preventive treatment of relapses are not clearly established but should associate plasmatherapy and caution to triggers of relapses. Therapeutic perspectives are focused on the development of concentrated plasma-derived ADAMTS13 or recombinant ADAMTS13.

Url:
DOI: 10.1007/s00467-008-0863-5


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:5644B9A6905FD47BEF714BCEA5AB40E6FB4281A5

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children</title>
<author>
<name sortKey="Loirat, Chantal" sort="Loirat, Chantal" uniqKey="Loirat C" first="Chantal" last="Loirat">Chantal Loirat</name>
</author>
<author>
<name sortKey="Girma, Jean Pierre" sort="Girma, Jean Pierre" uniqKey="Girma J" first="Jean-Pierre" last="Girma">Jean-Pierre Girma</name>
</author>
<author>
<name sortKey="Desconclois, Celine" sort="Desconclois, Celine" uniqKey="Desconclois C" first="Céline" last="Desconclois">Céline Desconclois</name>
</author>
<author>
<name sortKey="Coppo, Paul" sort="Coppo, Paul" uniqKey="Coppo P" first="Paul" last="Coppo">Paul Coppo</name>
</author>
<author>
<name sortKey="Veyradier, Agnes" sort="Veyradier, Agnes" uniqKey="Veyradier A" first="Agnès" last="Veyradier">Agnès Veyradier</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5644B9A6905FD47BEF714BCEA5AB40E6FB4281A5</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1007/s00467-008-0863-5</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-X4C7J8TC-L/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001897</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001897</idno>
<idno type="wicri:Area/Istex/Curation">001897</idno>
<idno type="wicri:Area/Istex/Checkpoint">000764</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000764</idno>
<idno type="wicri:doubleKey">0931-041X:2008:Loirat C:thrombotic:thrombocytopenic:purpura</idno>
<idno type="wicri:Area/Main/Merge">002A76</idno>
<idno type="wicri:Area/Main/Curation">002A50</idno>
<idno type="wicri:Area/Main/Exploration">002A50</idno>
<idno type="wicri:Area/France/Extraction">000179</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children</title>
<author>
<name sortKey="Loirat, Chantal" sort="Loirat, Chantal" uniqKey="Loirat C" first="Chantal" last="Loirat">Chantal Loirat</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Néphrologie, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, Université Paris VII, 48 Boulevard Sérurier, 75019, Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre National de Référence des Microangiopathies Thrombotiques de l’adulte et de l’enfant, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">France</country>
</affiliation>
</author>
<author>
<name sortKey="Girma, Jean Pierre" sort="Girma, Jean Pierre" uniqKey="Girma J" first="Jean-Pierre" last="Girma">Jean-Pierre Girma</name>
<affiliation wicri:level="4">
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm U770, Université Paris XI, Le Kremlin Bicêtre</wicri:regionArea>
<orgName type="university">Université Paris-Sud</orgName>
<placeName>
<settlement type="city">Orsay</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Desconclois, Celine" sort="Desconclois, Celine" uniqKey="Desconclois C" first="Céline" last="Desconclois">Céline Desconclois</name>
<affiliation wicri:level="4">
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm U770, Université Paris XI, Le Kremlin Bicêtre</wicri:regionArea>
<orgName type="university">Université Paris-Sud</orgName>
<placeName>
<settlement type="city">Orsay</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d’Hématologie biologique, Hôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris, Clamart</wicri:regionArea>
<wicri:noRegion>Clamart</wicri:noRegion>
<wicri:noRegion>Clamart</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Coppo, Paul" sort="Coppo, Paul" uniqKey="Coppo P" first="Paul" last="Coppo">Paul Coppo</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre National de Référence des Microangiopathies Thrombotiques de l’adulte et de l’enfant, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d’Hématologie clinique, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris, Université Paris VI, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Veyradier, Agnes" sort="Veyradier, Agnes" uniqKey="Veyradier A" first="Agnès" last="Veyradier">Agnès Veyradier</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Centre National de Référence des Microangiopathies Thrombotiques de l’adulte et de l’enfant, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm U770, Université Paris XI, Le Kremlin Bicêtre</wicri:regionArea>
<orgName type="university">Université Paris-Sud</orgName>
<placeName>
<settlement type="city">Orsay</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d’Hématologie biologique, Hôpital Antoine Béclère, Assistance Publique-Hôpitaux de Paris, Clamart</wicri:regionArea>
<wicri:noRegion>Clamart</wicri:noRegion>
<wicri:noRegion>Clamart</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Pediatric Nephrology</title>
<title level="j" type="sub">Journal of the International Pediatric Nephrology Association</title>
<title level="j" type="abbrev">Pediatr Nephrol</title>
<idno type="ISSN">0931-041X</idno>
<idno type="eISSN">1432-198X</idno>
<imprint>
<publisher>Springer-Verlag</publisher>
<pubPlace>Berlin/Heidelberg</pubPlace>
<date type="published" when="2009-01-01">2009-01-01</date>
<biblScope unit="volume">24</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="19">19</biblScope>
<biblScope unit="page" to="29">29</biblScope>
</imprint>
<idno type="ISSN">0931-041X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0931-041X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>ADAMTS13</term>
<term>Plasma exchange</term>
<term>Plasmatherapy</term>
<term>Thrombotic thrombocytopenic purpura</term>
<term>Upshaw-Schulman syndrome</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Thrombotic thrombocytopenic purpura (TTP) related to a severely deficient activity of the von Willebrand factor cleaving protease, ADAMTS (A Disintegrin And Metalloprotease with ThromboSpondin type 1 repeats) 13, is a life-threatening event, the onset of which may occur as early as childhood. TTP is either inherited (Upshaw-Schulman syndrome) via ADAMTS13 gene mutations (neonatal onset) or acquired via anti-ADAMTS13 autoantibodies (childhood onset). TTP is due to platelet- and von-Willebrand-factor-rich thrombi of the microvasculature, inducing mechanical hemolytic anemia, consumption thrombocytopenia, and multivisceral ischemia. Clinical course consists of relapsing acute events triggered mostly by infections, associated icterus and hyperbilirubinemia, severe hemolytic anemia with schistocytosis and a negative Coombs test, severe thrombocytopenia, and sometimes symptoms related to visceral ischemia (renal failure, central nervous system vascular events, other organ failure). The recently available ADAMTS13 laboratory investigation combining measurement of ADAMTS13 activity in plasma, search for an ADAMTS13 circulating inhibitor, and anti-ADAMTS13 IgG and ADAMTS13 gene sequencing is a crucial addition to TTP diagnosis. Plasma exchanges are first-line treatment of acquired TTP, combined with steroids and immunosuppressive drugs. Curative treatment of acute events in Upshaw-Schulman syndrome relies on plasma infusions (provider of active ADAMTS13). Guidelines for preventive treatment of relapses are not clearly established but should associate plasmatherapy and caution to triggers of relapses. Therapeutic perspectives are focused on the development of concentrated plasma-derived ADAMTS13 or recombinant ADAMTS13.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Orsay</li>
<li>Paris</li>
</settlement>
<orgName>
<li>Université Paris-Sud</li>
</orgName>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Loirat, Chantal" sort="Loirat, Chantal" uniqKey="Loirat C" first="Chantal" last="Loirat">Chantal Loirat</name>
</region>
<name sortKey="Coppo, Paul" sort="Coppo, Paul" uniqKey="Coppo P" first="Paul" last="Coppo">Paul Coppo</name>
<name sortKey="Coppo, Paul" sort="Coppo, Paul" uniqKey="Coppo P" first="Paul" last="Coppo">Paul Coppo</name>
<name sortKey="Desconclois, Celine" sort="Desconclois, Celine" uniqKey="Desconclois C" first="Céline" last="Desconclois">Céline Desconclois</name>
<name sortKey="Desconclois, Celine" sort="Desconclois, Celine" uniqKey="Desconclois C" first="Céline" last="Desconclois">Céline Desconclois</name>
<name sortKey="Girma, Jean Pierre" sort="Girma, Jean Pierre" uniqKey="Girma J" first="Jean-Pierre" last="Girma">Jean-Pierre Girma</name>
<name sortKey="Loirat, Chantal" sort="Loirat, Chantal" uniqKey="Loirat C" first="Chantal" last="Loirat">Chantal Loirat</name>
<name sortKey="Loirat, Chantal" sort="Loirat, Chantal" uniqKey="Loirat C" first="Chantal" last="Loirat">Chantal Loirat</name>
<name sortKey="Veyradier, Agnes" sort="Veyradier, Agnes" uniqKey="Veyradier A" first="Agnès" last="Veyradier">Agnès Veyradier</name>
<name sortKey="Veyradier, Agnes" sort="Veyradier, Agnes" uniqKey="Veyradier A" first="Agnès" last="Veyradier">Agnès Veyradier</name>
<name sortKey="Veyradier, Agnes" sort="Veyradier, Agnes" uniqKey="Veyradier A" first="Agnès" last="Veyradier">Agnès Veyradier</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000179 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000179 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:5644B9A6905FD47BEF714BCEA5AB40E6FB4281A5
   |texte=   Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021